{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T19:43:03Z","timestamp":1715974983206},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroImage"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.neuroimage.2007.12.066","type":"journal-article","created":{"date-parts":[[2008,1,20]],"date-time":"2008-01-20T01:10:09Z","timestamp":1200791409000},"page":"1214-1221","source":"Crossref","is-referenced-by-count":25,"title":["Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions"],"prefix":"10.1016","volume":"40","author":[{"given":"Eric M.","family":"Reiman","sequence":"first","affiliation":[]},{"given":"Kewei","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Richard J.","family":"Caselli","sequence":"additional","affiliation":[]},{"given":"Gene E.","family":"Alexander","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Bandy","sequence":"additional","affiliation":[]},{"given":"Jennifer L.","family":"Adamson","sequence":"additional","affiliation":[]},{"given":"Wendy","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Ashley","family":"Cannon","sequence":"additional","affiliation":[]},{"given":"Elizabeth A.","family":"Stephan","sequence":"additional","affiliation":[]},{"given":"Dietrich A.","family":"Stephan","sequence":"additional","affiliation":[]},{"given":"Andreas","family":"Papassotiropoulos","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.neuroimage.2007.12.066_bib1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1176\/appi.ajp.159.5.738","article-title":"Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies","volume":"159","author":"Alexander","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-0270(94)90168-6","article-title":"Single-day apolipoprotein E genotyping","volume":"53","author":"Crook","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib4","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib5","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","article-title":"Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo","volume":"98","author":"Fassbender","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib7","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1101\/gr.204001","article-title":"Trimming, weighting, and grouping SNPs in human case\u2013control association studies","volume":"11","author":"Hoh","year":"2001","journal-title":"Genome Res."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib8","doi-asserted-by":"crossref","first-page":"16576","DOI":"10.1074\/jbc.273.26.16576","article-title":"Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol","volume":"273","author":"Howland","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuron.2004.08.043","article-title":"The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease","volume":"44","author":"Hutter-Paier","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib10","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib11","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/01.ATV.20.10.2255","article-title":"Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu\u2013Asia aging study","volume":"20","author":"Kalmijn","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib12","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1471-2156-4-S1-S9","article-title":"Detecting susceptibility genes in case\u2013control studies using set association","volume":"4 Suppl 1","author":"Kim","year":"2003","journal-title":"BMC Genet."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","article-title":"Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease","volume":"137","author":"Kivipelto","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0404.2006.00685.x","article-title":"Cholesterol as a risk factor for Alzheimer's disease\u2014epidemiological evidence","volume":"185","author":"Kivipelto","year":"2006","journal-title":"Acta Neurol. Scand., Suppl."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0404.2006.00679.x","article-title":"Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology","volume":"185","author":"Mahley","year":"2006","journal-title":"Acta Neurol. Scand., Suppl."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01213011-200505000-00003","article-title":"A multilocus approach to the antihypertensive pharmacogenetics of hydrochlorothiazide","volume":"15","author":"Maitland-van der Zee","year":"2005","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib18","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1212\/01.WNL.0000161870.78572.A5","article-title":"High total cholesterol levels in late life associated with a reduced risk of dementia","volume":"64","author":"Mielke","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng0996-55","article-title":"Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides","volume":"14","author":"Miyata","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/10665270360688192","article-title":"Set association analysis of SNP case\u2013control and microarray data","volume":"10","author":"Ott","year":"2003","journal-title":"J. Comput. Biol."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4088\/JCP.v67n0418","article-title":"Genetics, transcriptomics, and proteomics of Alzheimer's disease","volume":"67","author":"Papassotiropoulos","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib23","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4088\/JCP.v66n0720","article-title":"A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease","volume":"66","author":"Papassotiropoulos","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000070182.02537.84","article-title":"Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology","volume":"61","author":"Pappolla","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nn0403-345","article-title":"Alzheimer's disease: the cholesterol connection","volume":"6","author":"Puglielli","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","article-title":"Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib27","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1006\/nbdi.2001.0422","article-title":"A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease","volume":"8","author":"Refolo","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM199603213341202","article-title":"Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E","volume":"334","author":"Reiman","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib29","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1073\/pnas.061509598","article-title":"Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease","volume":"98","author":"Reiman","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib30","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1073\/pnas.0500579102","article-title":"Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism","volume":"102","author":"Reiman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0404.2006.00688.x","article-title":"Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease","volume":"185","author":"Rockwood","year":"2006","journal-title":"Acta Neurol. Scand., Suppl."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib32","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(05)70248-9","article-title":"Cholesterol in Alzheimer's disease","volume":"4","author":"Shobab","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0197-4580(95)02067-5","article-title":"Intraneuronal beta-amyloid immunoreactivity in the CNS","volume":"17","author":"Sparks","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.62.5.753","article-title":"Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results","volume":"62","author":"Sparks","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/exnr.1994.1044","article-title":"Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol","volume":"126","author":"Sparks","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/exnr.1994.1019","article-title":"Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype","volume":"125","author":"Strittmatter","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib45","article-title":"Co-Planar Stereotaxic Atlas of the Human Brain","author":"Talairach","year":"1998"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib38","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archinte.163.9.1053","article-title":"Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study","volume":"163","author":"Tan","year":"2003","journal-title":"Arch Intern. Med."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib40","first-page":"1030","article-title":"Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro","volume":"145","author":"Wisniewski","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0896-6273(03)00840-7","article-title":"Cholesterol and the biology of Alzheimer's disease","volume":"41","author":"Wolozin","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib42","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuroimage.2007.12.066_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-5-20","article-title":"Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease","volume":"5","author":"Wolozin","year":"2007","journal-title":"BMC Medicine"},{"key":"10.1016\/j.neuroimage.2007.12.066_bib44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archpsyc.62.2.217","article-title":"Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study","volume":"62","author":"Zandi","year":"2005","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["NeuroImage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053811907011718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053811907011718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T12:26:16Z","timestamp":1546345576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053811907011718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1053811907011718"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroimage.2007.12.066","relation":{},"ISSN":["1053-8119"],"issn-type":[{"value":"1053-8119","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}